Antileukemic efficacy in vitro of talazoparib and APE1 inhibitor III combined with decitabine in myeloid malignancies - Samra, Vanessa; Flach, Johanna; Naumann, Nicole; Brendel, Susanne; Kleiner, Helga; Weiß, Christel; Seifarth, Wolfgang; Nowak, Daniel; Hofmann, Wolf-Karsten; Fabarius, Alice; Popp, Henning (Cancers, 2019)
Gesehen am 06.12.2019